Singapore markets closed
Straits Times Index
3,297.55 -26.98 (-0.81%) Nikkei
38,814.56 +94.09 (+0.24%) Hang Seng
17,941.78 -170.85 (-0.94%) FTSE 100
8,146.86 -16.81 (-0.21%) Bitcoin USD
66,075.21 -78.66 (-0.12%) CMC Crypto 200
1,403.34 -14.54 (-1.03%)
Dr. Reddy's Laboratories Limited (DRREDDY.NS)
NSE - NSE Real-time price. Currency in INR
Add to watchlist
At close: 03:30PM IST
Currency in INR
Valuation measures4
| Market cap (intra-day) | 1.01T |
| Enterprise value | 951.85B |
| Trailing P/E | 18.22 |
| Forward P/E | 21.14 |
| PEG ratio (5-yr expected) | 3.68 |
| Price/sales (ttm) | 3.63 |
| Price/book (mrq) | 3.61 |
| Enterprise value/revenue | 3.41 |
| Enterprise value/EBITDA | 10.76 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.30 |
| 52-week change 3 | 24.72% |
| S&P500 52-week change 3 | 23.76% |
| 52-week high 3 | 6,505.90 |
| 52-week low 3 | 4,862.05 |
| 50-day moving average 3 | 6,004.57 |
| 200-day moving average 3 | 5,867.89 |
Share statistics
| Avg vol (3-month) 3 | 441.31k |
| Avg vol (10-day) 3 | 542.05k |
| Shares outstanding 5 | 166.54M |
| Implied shares outstanding 6 | 166.8M |
| Float 8 | 119.84M |
| % held by insiders 1 | 29.03% |
| % held by institutions 1 | 46.73% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 40 |
| Forward annual dividend yield 4 | 0.66% |
| Trailing annual dividend rate 3 | 40.00 |
| Trailing annual dividend yield 3 | 0.66% |
| 5-year average dividend yield 4 | 0.62 |
| Payout ratio 4 | 11.98% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 15 Jul 2024 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 28 Aug 2006 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Mar 2024 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 19.95% |
| Operating margin (ttm) | 18.31% |
Management effectiveness
| Return on assets (ttm) | 11.51% |
| Return on equity (ttm) | 21.77% |
Income statement
| Revenue (ttm) | 279.16B |
| Revenue per share (ttm) | 1,677.73 |
| Quarterly revenue growth (yoy) | 12.50% |
| Gross profit (ttm) | N/A |
| EBITDA | 79.01B |
| Net income avi to common (ttm) | 55.68B |
| Diluted EPS (ttm) | 334.08 |
| Quarterly earnings growth (yoy) | 36.30% |
Balance sheet
| Total cash (mrq) | 81.47B |
| Total cash per share (mrq) | 489.23 |
| Total debt (mrq) | 20.02B |
| Total debt/equity (mrq) | 7.14% |
| Current ratio (mrq) | 2.58 |
| Book value per share (mrq) | 1,684.70 |
Cash flow statement
| Operating cash flow (ttm) | 45.43B |
| Levered free cash flow (ttm) | 12.23B |
© 2024 Yahoo. All rights reserved.